BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 6541973)

  • 1. Combination chemotherapy with cisplatin, carmustine, dacarbazine, and tamoxifen in metastatic melanoma.
    Del Prete SA; Maurer LH; O'Donnell J; Forcier RJ; LeMarbre P
    Cancer Treat Rep; 1984 Nov; 68(11):1403-5. PubMed ID: 6541973
    [No Abstract]   [Full Text] [Related]  

  • 2. Therapy for metastatic melanoma: effective combination of dacarbazine, carmustine, cisplatin and tamoxifen.
    Fierro MT; Bertero M; Novelli M; Appino A; Doveil GC; Colonna S; Bernengo MG
    Melanoma Res; 1993 Apr; 3(2):127-31. PubMed ID: 8518551
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination chemotherapy (dacarbazine, carmustine, cisplastin, and tamoxifen) in advanced melanoma.
    Tan EH; Ang PT
    Singapore Med J; 1996 Apr; 37(2):165-7. PubMed ID: 8942255
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase II study of second-line therapy with DTIC, BCNU, cisplatin and tamoxifen (Dartmouth regimen) chemotherapy in patients with malignant melanoma previously treated with dacarbazine.
    Propper DJ; Braybrooke JP; Levitt NC; O'Byrne K; Christodoulos K; Han C; Talbot DC; Ganesan TS; Harris AL
    Br J Cancer; 2000 Jun; 82(11):1759-63. PubMed ID: 10839287
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dacarbazine-based chemotherapy for metastatic melanoma: thirty-year experience overview.
    Serrone L; Zeuli M; Sega FM; Cognetti F
    J Exp Clin Cancer Res; 2000 Mar; 19(1):21-34. PubMed ID: 10840932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized phase III study comparing dacarbazine, BCNU, cisplatin and tamoxifen with dacarbazine and interferon in advanced melanoma.
    Middleton MR; Lorigan P; Owen J; Ashcroft L; Lee SM; Harper P; Thatcher N
    Br J Cancer; 2000 Mar; 82(6):1158-62. PubMed ID: 10735499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination chemotherapy and hormonal therapy in the treatment of malignant melanoma.
    McClay EF; Mastrangelo MJ; Bellet RE; Berd D
    Cancer Treat Rep; 1987 May; 71(5):465-9. PubMed ID: 3567970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biochemotherapy with carmustine, cisplatin, dacarbazine, tamoxifen and low-dose interleukin-2 for patients with metastatic malignant melanoma.
    Su PJ; Chen JS; Liaw CC; Chang HK; Wang HM; Yang TS; Lin YC; Liau CT; Yang HY; Yeh KY; Ho MM; Chang NJ; Wang CH; Chang JW
    Chang Gung Med J; 2011; 34(5):478-86. PubMed ID: 22035892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The chemohormonal therapy of metastatic melanoma: possible benefit of tamoxifen.
    Crowell EB; Higa GM
    W V Med J; 1993 Jun; 89(6):233-5. PubMed ID: 8322461
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination chemotherapy of metastatic melanoma.
    Berd D; Mastrangelo MJ
    J Clin Oncol; 1995 Mar; 13(3):796-7. PubMed ID: 7884439
    [No Abstract]   [Full Text] [Related]  

  • 11. [Chemotherapy in combination with laser coagulation or interstitial hyperthermia--effective combined therapy for disseminated skin melanoma].
    Akimov MA; Gel'fond ML; Gershanovich ML; Barchuk AS
    Vopr Onkol; 2003; 49(3):312-5. PubMed ID: 12926212
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of metastatic malignant melanoma with dacarbazine and cisplatin.
    Oratz R; Speyer JL; Green M; Blum R; Wernz JC; Muggia FM
    Cancer Treat Rep; 1987 Sep; 71(9):877-8. PubMed ID: 3621224
    [No Abstract]   [Full Text] [Related]  

  • 13. What can we learn from phase II adjuvant trials in melanoma?
    Keilholz U; Suciu S; Eggermont AM
    Br J Cancer; 2000 Jul; 83(1):6-7. PubMed ID: 10883660
    [No Abstract]   [Full Text] [Related]  

  • 14. The effect of tamoxifen and cisplatin on the disease-free and overall survival of patients with high risk malignant melanoma.
    McClay EF; McClay ME; Monroe L; Baron PL; Cole DJ; O'Brien PH; Metcalf JS; Maize JC
    Br J Cancer; 2000 Jul; 83(1):16-21. PubMed ID: 10883662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bleomycin, carmustine, vincristine, and dacarbazine in patients with metastatic malignant melanoma.
    Cohen SM; Ohnuma T; Cheung T; Holland JF
    Cancer Treat Rep; 1983 Oct; 67(10):947-8. PubMed ID: 6194881
    [No Abstract]   [Full Text] [Related]  

  • 16. Outpatient chemoimmunotherapy for the treatment of metastatic melanoma.
    Thompson JA; Gold PJ; Fefer A
    Semin Oncol; 1997 Feb; 24(1 Suppl 4):S44-8. PubMed ID: 9122734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemotherapy for stage 4 melanoma: a three-year experience with cisplatin, DTIC, BCNU, and tamoxifen.
    Reintgen D; Saba H
    Semin Surg Oncol; 1993; 9(3):251-5. PubMed ID: 8516613
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase II trial of vinblastine, bleomycin, and cisplatin (VBP) followed by dacarbazine and mitolactol in metastatic melanoma.
    Richman SP; Woodcock TM; Kubota TT; Blumenreich MS; Gentile PS; Allegra JC
    Cancer Treat Rep; 1984 Nov; 68(11):1395-6. PubMed ID: 6209008
    [No Abstract]   [Full Text] [Related]  

  • 19. Combination chemotherapy with dacarbazine and vindesine in the treatment of metastatic malignant melanoma.
    Vorobiof DA; Sarli R; Falkson G
    Cancer Treat Rep; 1986 Jul; 70(7):927-8. PubMed ID: 3719588
    [No Abstract]   [Full Text] [Related]  

  • 20. Treatment of metastatic malignant melanoma with dacarbazine plus tamoxifen.
    Cocconi G; Bella M; Calabresi F; Tonato M; Canaletti R; Boni C; Buzzi F; Ceci G; Corgna E; Costa P
    N Engl J Med; 1992 Aug; 327(8):516-23. PubMed ID: 1635566
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.